Evidence map›Paper›PMID 24725432›Full record

ArticleThe Journal of nutritional biochemistry2014

Chromium enhances insulin responsiveness via AMPK.

Nolan J Hoffman, Brent A Penque, Kirk M Habegger, Whitney Sealls, Lixuan Tackett, Jeffrey S Elmendorf

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in The Journal of nutritional biochemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07711587 (A Pilot Study Investigating the Effects of Diaplex Supplementation on Glucose Regulation in Otherwise Healthy Adults With Elevated Blood Glucose Levels), which is not on this map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07711587 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

A Pilot Study Investigating the Effects of Diaplex Supplementation on Glucose Regulation in Otherwise Healthy Adults With Elevated Blood Glucose Levels

TypeinterventionalSponsorStandard Process Inc.Ran2026 to 2027Enrolled40ConditionsInsulin Sensitivity, Healthy AdultArmsDiaplex, Placebo
3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 59 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Nolan J HoffmanDepartment of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Brent A PenqueDepartment of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Kirk M HabeggerDepartment of Biochemistry and Molecular Biology, Center for Diabetes Research, Indiana University School of Medicine, Indianapolis, IN 46202, USA; Department of Medicine - Endocrinology, Diabetes & Metabolism University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Whitney SeallsDepartment of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Lixuan TackettDepartment of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Jeffrey S ElmendorfDepartment of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, IN 46202, USA; Department of Biochemistry and Molecular Biology, Center for Diabetes Research, Indiana University School of Medicine, Indianapolis, IN 46202, USA. Electronic address: jelmendo@iupui.edu.
Indiana University School of MedicineIndiana University – Purdue University Indianapolis · US

Funding

RESEARCH TRAINING PROGRAM IN DIABETES AND OBESITYT32DK064466 · NIDDK · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI Carmella Evans-Molina, RONALD C WEK · 2003 to 2026
$5.2M
Training in Vascular Biology and MedicineT32HL079995 · NHLBI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI MARCH, KEITH LEONARD · 2005 to 2014
$2.2M
Mechanisms of Membrane-Based Insulin Resistance & Therapeutic Reversal StrategiesR01DK082773 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI ELMENDORF, JEFFREY S · 2009 to 2012
$1.4M
CHROMIUM ENHANCES INSULIN &GLUT4 ACTION VIA LIPID RAFTSR01AT001846 · NCCIH · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI ELMENDORF, JEFFREY S · 2004 to 2008
$1.4M
NCCIH NIH HHS AT001846NCCIH NIH HHS R01 AT001846NHLBI NIH HHS HL079995NHLBI NIH HHS T32 HL079995NIDDK NIH HHS DK082773NIDDK NIH HHS DK082773-01S1NIDDK NIH HHS R01 DK082773NIDDK NIH HHS T32 DK064466NIDDK NIH HHS T32-DK064466
6 · The paper itself

Abstract

Trivalent chromium (Cr(3+)) is known to improve glucose homeostasis. Cr(3+) has been shown to improve plasma membrane-based aspects of glucose transporter GLUT4 regulation and increase activity of the cellular energy sensor 5' AMP-activated protein kinase (AMPK). However, the mechanism(s) by which Cr(3+) improves insulin responsiveness and whether AMPK mediates this action is not known. In this study we tested if Cr(3+) protected against physiological hyperinsulinemia-induced plasma membrane cholesterol accumulation, cortical filamentous actin (F-actin) loss and insulin resistance in L6 skeletal muscle myotubes. In addition, we performed mechanistic studies to test our hypothesis that AMPK mediates the effects of Cr(3+) on GLUT4 and glucose transport regulation. Hyperinsulinemia-induced insulin-resistant L6 myotubes displayed excess membrane cholesterol and diminished cortical F-actin essential for effective glucose transport regulation. These membrane and cytoskeletal abnormalities were associated with defects in insulin-stimulated GLUT4 translocation and glucose transport. Supplementing the culture medium with pharmacologically relevant doses of Cr(3+) in the picolinate form (CrPic) protected against membrane cholesterol accumulation, F-actin loss, GLUT4 dysregulation and glucose transport dysfunction. Insulin signaling was neither impaired by hyperinsulinemic conditions nor enhanced by CrPic, whereas CrPic increased AMPK signaling. Mechanistically, siRNA-mediated depletion of AMPK abolished the protective effects of CrPic against GLUT4 and glucose transport dysregulation. Together these findings suggest that the micronutrient Cr(3+), via increasing AMPK activity, positively impacts skeletal muscle cell insulin sensitivity and glucose transport regulation.

Indexed as

ActinsAMP-Activated Protein KinasesAnimalsCell MembraneCells, CulturedCholesterolChromiumDietary SupplementsGlucoseGlucose Transporter Type 4HyperinsulinismInsulinMuscle Fibers, SkeletalMuscle, SkeletalPicolinic AcidsRatsActinsAMP-Activated Protein KinasesCholesterolChromiumGlucoseGlucose Transporter Type 4Insulinpicolinic acidPicolinic AcidsSlc2a4 protein, ratAMP-activated protein kinaseCholesterolChromiumGLUT4Insulin

Identifiers

PMID24725432
PMCPMC4030743
OpenAlexW2024583092

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.